Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to -$61.9 million.

  • Regenxbio's Profit After Tax fell 393.31% to -$61.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$177.9 million, marking a year-over-year increase of 2549.78%. This contributed to the annual value of -$227.1 million for FY2024, which is 1381.13% up from last year.
  • Per Regenxbio's latest filing, its Profit After Tax stood at -$61.9 million for Q3 2025, which was down 393.31% from -$70.9 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Profit After Tax registered a high of $294.0 million during Q4 2021, and its lowest value of -$76.7 million during Q1 2022.
  • Over the past 5 years, Regenxbio's median Profit After Tax value was -$61.9 million (recorded in 2023), while the average stood at -$40.5 million.
  • Within the past 5 years, the most significant YoY rise in Regenxbio's Profit After Tax was 73584.91% (2021), while the steepest drop was 76437.27% (2021).
  • Quarter analysis of 5 years shows Regenxbio's Profit After Tax stood at $294.0 million in 2021, then tumbled by 120.38% to -$59.9 million in 2022, then decreased by 4.93% to -$62.9 million in 2023, then rose by 18.61% to -$51.2 million in 2024, then fell by 21.01% to -$61.9 million in 2025.
  • Its Profit After Tax was -$61.9 million in Q3 2025, compared to -$70.9 million in Q2 2025 and $6.1 million in Q1 2025.